HOME最近の話題次回の研究会研究会の歩み役立ち情報keywords意見交換リンク

2008年10月27日(月)

????Orlistat??????????

投稿者: ????????

????????EMEA?European Medicines Agency?????????CHMP?Committee for Medicinal Products for Human Use??23??????Orlistat 60mg (Alli) ????????????????????????????????????

European Medicines Agency recommends first switch from prescription-only to non-prescription for a centrally authorised medicine
????(EMEA?Press?release 2008.10.23)

????????EMEA?2006?1?????????????????????EU???????????????1?????????????????EU???27?????????????????

GUIDELINE ON CHANGING THE CLASSIFICATION FOR THE SUPPLY OF A MEDICINAL PRODUCT FOR HUMAN USE
?????(EMEA Revision January 2006)

alli(EPARs for authorised medicinal products for human use)
?????http://www.emea.europa.eu/humandocs/Humans/EPAR/alli/alli.htm

???????????GSK??PJ????? ?Alli??????????????????????????????????????????????????????

???????????????????????????????????????????????????????2005.4.4??????????????????Orlistat ??????????????????????

?????????????????????KES524???????????????????????2007.11.29????????????????cetilistat???????S-2367 ?????????????????rimonabant ????????????????Orlistat ???????????????????????????

?????TOPICS
???2008.10.24?????Rimonabant??????????
???2007.02.08?OTC?????????????
???2006.01.24???????????????????????????

???Orlistat switch approved by European Medicines Agency
????(PJ online 2008.10.24?????????????????????
http://www.pjonline.com/news
/orlistat_switch_approved_by_european_medicines_agency

Sanofi’s Acomplia Failure Threatens Obesity Drug Development
????(bloomberg.com 2008.10.24?
http://www.bloomberg.com/apps/news?pid=20601085&sid=asNW.g2.84QI&refer=europe

Topに戻る  

コメント (0)

この記事にはまだコメントがついていません。

現在、この記事へのコメントは頂いておりません。

Copyright(C) Ryomo Apotheker Network, All rights reserved, since 2004